SEC CIK 1228718
Epstein Jeff
Reported ownership across 5 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| SSTKview stock → | 28,890 | 2020-06-04 |
| OKTAview stock → | 12,811 | 2026-06-17 |
| BKNGview stock → | 8,257 | 2019-06-05 |
| ORCLview stock → | 6,202 | 2010-09-30 |
| ADSKview stock → | 2,865 | 2026-06-17 |
Position History — OKTA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — OKTA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-17 | Option exercise (derivative) | 2,487 | $0.00 | 0 |
| 2026-06-17 | Option exercise | 2,487 | $0.00 | 12,811 |
| 2025-06-24 | Grant / award (derivative) | 2,487 | $0.00 | 2,487 |
| 2025-06-20 | Option exercise (derivative) | 2,832 | $0.00 | 0 |
| 2025-06-20 | Option exercise | 2,832 | $0.00 | 10,324 |
| 2024-06-20 | Grant / award (derivative) | 2,832 | $0.00 | 2,832 |
| 2024-06-19 | Option exercise (derivative) | 2,818 | $0.00 | 0 |
| 2024-06-19 | Option exercise | 2,818 | $0.00 | 7,492 |
| 2024-05-25 | Option exercise (derivative) | 478 | $0.00 | 0 |
| 2024-05-25 | Option exercise | 478 | $0.00 | 4,674 |
| 2023-06-22 | Grant / award (derivative) | 2,818 | $0.00 | 2,818 |
| 2023-06-21 | Option exercise (derivative) | 2,378 | $0.00 | 0 |
| 2023-06-21 | Option exercise | 2,378 | $0.00 | 4,196 |
| 2023-05-25 | Option exercise (derivative) | 478 | $0.00 | 478 |
| 2023-05-25 | Option exercise | 478 | $0.00 | 1,818 |
| 2022-06-21 | Grant / award (derivative) | 2,378 | $0.00 | 2,378 |
| 2022-06-17 | Option exercise (derivative) | 862 | $0.00 | 0 |
| 2022-06-17 | Option exercise | 862 | $0.00 | 1,340 |
| 2022-05-25 | Option exercise (derivative) | 478 | $0.00 | 956 |
| 2022-05-25 | Option exercise | 478 | $0.00 | 478 |
| 2021-06-17 | Grant / award (derivative) | 862 | $0.00 | 862 |
| 2021-05-25 | Grant / award (derivative) | 1,434 | $0.00 | 1,434 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.